[1]
Lembas, A., Załęski, A., Mikuła, T., Jabłońska, J., Barczak, S., Badura, B. and Wiercińska-Drapało, A. 2024. Differences in the course of hepatocellular carcinoma depending on the DAA treatment. Prospects in Pharmaceutical Sciences. 22, 3 (Aug. 2024), 114–119. DOI:https://doi.org/10.56782/pps.236.